RadNet (RDNT)
(Delayed Data from NSDQ)
$56.22 USD
-0.47 (-0.83%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $60.45 +4.23 (7.52%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$56.22 USD
-0.47 (-0.83%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $60.45 +4.23 (7.52%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth C Momentum B VGM
Zacks News
3 Stocks to Bank on the Buoyant Outpatient Home Health Industry
by Trina Mukherjee
Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and USPH are well-poised to gain from the prospects.
RadNet (RDNT) Q3 Earnings Top Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of 5.00% and -2.79%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
RadNet (RDNT) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
RadNet (RDNT) closed at $31.96 in the latest trading session, marking a -0.87% move from the prior day.
RadNet (RDNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics
by Zacks Equity Research
Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics
3 Top Stocks From the Buoyant Outpatient Home Health Industry
by Trina Mukherjee
Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. EHC, RDNT and USPH are well-poised to gain from the prospects.
New Strong Buy Stocks for September 20th
by Zacks Equity Research
RDNT, ACH, FNF, MG, and TPR have been added to the Zacks Rank #1 (Strong Buy) List on September 20, 2021.
New Strong Buy Stocks for September 14th
by Zacks Equity Research
CPRI, MAN, RDNT, HSII, and OLN have been added to the Zacks Rank #1 (Strong Buy) List on September 14, 2021.
New Strong Buy Stocks for September 1st
by Zacks Equity Research
BBY, CNHI, RDNT, SALM, and TOL have been added to the Zacks Rank #1 (Strong Buy) List on September 1, 2021.
New Strong Buy Stocks for August 30th
by Zacks Equity Research
DSKE, HNGR, GPS, SCSC, and RDNT have been added to the Zacks Rank #1 (Strong Buy) List on August 30, 2021
Zacks.com featured highlights include: NBT Bancorp, Bio-Rad Laboratories, RadNet, Arbor Realty Trust and Cathay General Bancorp
by Zacks Equity Research
Zacks.com featured highlights include: NBT Bancorp, Bio-Rad Laboratories, RadNet, Arbor Realty Trust and Cathay General Bancorp
New Analyst Coverage Puts Spotlight on These 5 Stocks
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks might lead to solid price appreciation for stocks like NBTB, BIO, RDNT, ABR and CATY.
New Strong Buy Stocks for August 19th
by Zacks Equity Research
AOSL, CCS, GMS, RDNT, and SALM have been added to the Zacks Rank #1 (Strong Buy) List on August 19, 2021.
RadNet (RDNT) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of 92.86% and 2.18%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
RadNet (RDNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RadNet (RDNT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
RadNet (RDNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Strength Seen in RadNet (RDNT): Can Its 5.4% Jump Turn into More Strength?
by Zacks Equity Research
RadNet (RDNT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RadNet (RDNT) Soars 10%: Is Further Upside Left in the Stock?
by Zacks Equity Research
RadNet (RDNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RadNet (RDNT) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of 180.00% and 7.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
RadNet (RDNT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RadNet (RDNT) Upgraded to Buy: Here's Why
by Zacks Equity Research
RadNet (RDNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
RadNet (RDNT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of 25.00% and 1.82%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: RadNet (RDNT) Q4 Earnings Expected to Decline
by Zacks Equity Research
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RadNet (RDNT) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
RadNet (RDNT) delivered earnings and revenue surprises of 350.00% and 12.72%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Time to Buy U.S. Stocks in October? Zacks Market Strategy
by John Blank
Here's the mantra: Don't fight the Fed. Don't fight the ECB in Europe, the BoE in the U.K., the BoJ in Japan, and the People's Bank of China. All major central bank players brought out the "anything goes" monetary policy artillery.